These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4936040)

  • 1. Antilipidemic effect of nafenoic acid.
    Russo C; Mendlowitz M
    Clin Pharmacol Ther; 1971; 12(4):676-7. PubMed ID: 4936040
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of CH 13.437 in different types of hyperlipidemia.
    Harvengt C
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:298+. PubMed ID: 4559547
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
    Malhotra SC; Ahuja MM
    Indian J Med Res; 1971 Oct; 59(10):1621-32. PubMed ID: 5159000
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of primary hyperlipoproteinaemias with a tetralin derivative (Su-13'437).
    Fellin R; Fedele D; Bagnariol G; Pagnan A; Crepaldi G
    Atherosclerosis; 1973; 17(3):383-8. PubMed ID: 4577009
    [No Abstract]   [Full Text] [Related]  

  • 5. The hypolipidemic effect of SU-13,437 in rats with natural endogenous hypertriglyceridemia.
    Lenz PH; Fleischman AI
    Lipids; 1971 Nov; 6(11):783-6. PubMed ID: 5127473
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of tibric acid (CP 18,524) a new hypolipidemic agent.
    Sirtori CR; Zoppi S; Quarisa B; Agradi E
    Pharmacol Res Commun; 1974 Oct; 6(5):445-56. PubMed ID: 4617230
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth and luteinizing hormone decreases during nafenoic acid therapy.
    Danowski TS; Fisher ER; Gonzalez AR; Khurana RC; Jung Y; Hancock RA; Vester JW
    Pol Med Sci Hist Bull; 1971 Oct; 14(4):148-53. PubMed ID: 5131072
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the effectiveness of the treatment of arteriosclerosis].
    Bobkova VI; Mazurova SV; Fomchenkov SI
    Kardiologiia; 1974 Jul; 14(7):108-13. PubMed ID: 4431129
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose-response to tibric acid: a new hypolipidemic drug in type IV hyperlipoproteinemia.
    Bielmann P; Brun D; Moorjani S; Gagné C; Lupien P; Tétreault L
    Clin Pharmacol Ther; 1975 May; 17(5):606-11. PubMed ID: 165029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of halofenate on serum lipids.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP; Mays J
    Clin Pharmacol Ther; 1973; 14(3):358-65. PubMed ID: 4572798
    [No Abstract]   [Full Text] [Related]  

  • 12. Preliminary evaluation of the hypolipidemic effects in man of a new phenolic ether (Su-13437, CIBA).
    Best MM; Duncan CH
    J Atheroscler Res; 1969; 10(1):103-6. PubMed ID: 5380895
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Lipid-lowering drugs after myocardial infarction.
    Lancet; 1975 Mar; 1(7905):501-2. PubMed ID: 46964
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic effect of Ciba 13437-Su in 40 patients with familial essential hyperlipemia].
    Schönbeck M; Forster G; Hirzel H; Jakab T; Rosenmund H
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1761-8. PubMed ID: 5451984
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of SU-13437--a new hypolipidemic drug in man.
    Bianchine JR; Weiss P; Peaston MJ; Hersey RM; Lasagna L
    Clin Pharmacol Ther; 1970; 11(1):97-105. PubMed ID: 5410898
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
    Dobordzhginidze LM
    Kardiologiia; 2004; 44(3):87-93. PubMed ID: 15489838
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of MK-185: a new hypolipidemic drug.
    Sirtori C; Hurwitz A; Sabih K; Azarnoff D
    Lipids; 1972 Feb; 7(2):96-9. PubMed ID: 4551950
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid-lowering effects of procetofene.
    Afschrift M; Mets T; Verdonk G
    Lancet; 1977 Aug; 2(8032):311. PubMed ID: 69930
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of CIBA 13,437-Su on serum cholesterol and triglycerides, plasma fibrinogen, fibrinolysis and platelet adhesiveness in patient with ischemic hert disease.
    Mannucci PM; Pareti F; Maggi CA; Diaguardi M
    Atherosclerosis; 1971; 13(1):1-8. PubMed ID: 4926863
    [No Abstract]   [Full Text] [Related]  

  • 20. Implications of 4S evidence on baseline lipid levels.
    Durrington PN
    Lancet; 1995 Jul; 346(8968):181. PubMed ID: 7661979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.